Entry
Name
Systemic lupus erythematosus - Homo sapiens (human)
Description
Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease characterised by the production of IgG autoantibodies that are specific for self-antigens, such as DNA, nuclear proteins and certain cytoplasmic components, in association with a diverse array of clinical manifestations. The primary pathological findings in patients with SLE are those of inflammation, vasculitis, immune complex deposition, and vasculopathy. Immune complexes comprising autoantibody and self-antigen is deposited particulary in the renal glomeruli and mediate a systemic inflammatory response by activating complement or via Fc{gamma}R-mediated neutrophil and macrophage activation. Activation of complement (C5) leads to injury both through formation of the membrane attack complex (C5b-9) or by generation of the anaphylatoxin and cell activator C5a. Neutrophils and macrophages cause tissue injury by the release of oxidants and proteases.
Class
Human Diseases; Immune disease
BRITE hierarchy
Pathway map
Disease
H00080 Systemic lupus erythematosus
Organism
Homo sapiens (human) [GN:
hsa ]
Gene
100293534 C4B_2; complement component 4B (Chido/Rodgers blood group), copy 2 [KO:K03989 ]
124905743 FCGR3B; low affinity immunoglobulin gamma Fc region receptor III-B [KO:K06463 ]
2903 GRIN2A; glutamate ionotropic receptor NMDA type subunit 2A [KO:K05209 ]
2904 GRIN2B; glutamate ionotropic receptor NMDA type subunit 2B [KO:K05210 ]
3108 HLA-DMA; major histocompatibility complex, class II, DM alpha [KO:K06752 ]
3109 HLA-DMB; major histocompatibility complex, class II, DM beta [KO:K06752 ]
3111 HLA-DOA; major histocompatibility complex, class II, DO alpha [KO:K06752 ]
3112 HLA-DOB; major histocompatibility complex, class II, DO beta [KO:K06752 ]
3113 HLA-DPA1; major histocompatibility complex, class II, DP alpha 1 [KO:K06752 ]
3115 HLA-DPB1; major histocompatibility complex, class II, DP beta 1 [KO:K06752 ]
3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 [KO:K06752 ]
3118 HLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752 ]
3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 [KO:K06752 ]
3120 HLA-DQB2; major histocompatibility complex, class II, DQ beta 2 [KO:K06752 ]
3122 HLA-DRA; major histocompatibility complex, class II, DR alpha [KO:K06752 ]
3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 [KO:K06752 ]
3125 HLA-DRB3; major histocompatibility complex, class II, DR beta 3 [KO:K06752 ]
3126 HLA-DRB4; major histocompatibility complex, class II, DR beta 4 [KO:K06752 ]
3127 HLA-DRB5; major histocompatibility complex, class II, DR beta 5 [KO:K06752 ]
54145 H2BC12L; H2B clustered histone 12 like [KO:K11252 ]
6628 SNRPB; small nuclear ribonucleoprotein polypeptides B and B1 [KO:K11086 ]
6632 SNRPD1; small nuclear ribonucleoprotein D1 polypeptide [KO:K11087 ]
6634 SNRPD3; small nuclear ribonucleoprotein D3 polypeptide [KO:K11088 ]
6738 RO60; Ro60, Y RNA binding protein [KO:K11089 ]
6741 SSB; small RNA binding exonuclease protection factor La [KO:K11090 ]
720 C4A; complement C4A (Chido/Rodgers blood group) [KO:K03989 ]
721 C4B; complement C4B (Chido/Rodgers blood group) [KO:K03989 ]
731 C8A; complement C8 alpha chain [KO:K03997 ]
732 C8B; complement C8 beta chain [KO:K03998 ]
733 C8G; complement C8 gamma chain [KO:K03999 ]
8290 H3-4; H3.4 histone, cluster member [KO:K11253 ]
Compound
Reference
Authors
Rahman A, Isenberg DA.
Title
Systemic lupus erythematosus.
Journal
Reference
Authors
Mok CC, Lau CS.
Title
Pathogenesis of systemic lupus erythematosus.
Journal
Reference
Authors
Clatworthy MR, Smith KG.
Title
B cells in glomerulonephritis: focus on lupus nephritis.
Journal
Reference
Authors
Couser WG.
Title
New insights into mechanisms of immune glomerular injury.
Journal
West J Med 160:440-6 (1994)
Reference
Authors
Cook HT, Botto M.
Title
Mechanisms of Disease: the complement system and the pathogenesis of systemic lupus erythematosus.
Journal
Reference
Authors
Carroll MC.
Title
A protective role for innate immunity in systemic lupus erythematosus.
Journal
Reference
Authors
Sturfelt G, Truedsson L.
Title
Complement and its breakdown products in SLE.
Journal
Reference
Authors
Lu L, Kaliyaperumal A, Boumpas DT, Datta SK.
Title
Major peptide autoepitopes for nucleosome-specific T cells of human lupus.
Journal
Reference
Authors
Zieve GW, Khusial PR.
Title
The anti-Sm immune response in autoimmunity and cell biology.
Journal
Reference
Authors
Scofield RH, Farris AD, Horsfall AC, Harley JB.
Title
Fine specificity of the autoimmune response to the Ro/SSA and La/SSB ribonucleoproteins.
Journal
Reference
Authors
Hoffman RW.
Title
T cells in the pathogenesis of systemic lupus erythematosus.
Journal
Related pathway
hsa04060 Cytokine-cytokine receptor interaction
hsa04610 Complement and coagulation cascades
hsa04612 Antigen processing and presentation
hsa04660 T cell receptor signaling pathway
hsa04662 B cell receptor signaling pathway
hsa04670 Leukocyte transendothelial migration
KO pathway